Comparison of the effects of oral and intravenous aspirin administration on platelet and peripheral vascular cyclo-oxygenase activity: studies in rats and in man.
D015121:6-Ketoprostaglandin F1 alpha / Q000378:metabolism / Q000652:urine; D000284:Administration, Oral; D000818:Animals; D001241:Aspirin / Q000008:administration & dosage* / Q000097:blood; D001682:Biological Availability; D001792:Blood Platelets / Q000201:enzymology; D001808:Blood Vessels / Q000187:drug effects* / Q000201:enzymology; D005260:Female; D005342:Fibrinolysis; D006801:Humans; D007275:Injections, Intravenous; D007700:Kinetics; D010974:Platelet Aggregation / Q000187:drug effects*; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism*; D051381:Rats; D013929:Thromboxane B2 / Q000097:blood / Q000378:metabolism / Q000652:urine
D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; D011451:Prostaglandin-Endoperoxide Synthases; D001241:Aspirin